跳至主要内容
临床试验/CTRI/2026/01/101585
CTRI/2026/01/101585尚未招募2 期

Evaluation of Efficacy of Polyherbal Formulation in Treatment of Hyperlipidemia: A Randomized Controlled Trial

Vd Vaishnavi Bhausaheb Ghodake1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2026年3月9日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
64
试验地点
1

研究概览

简要总结

A Randomized Comparative Clinical Study to Evaluate the Efficacy of Polyherbal formulation in the treatment of Hyperlipidemia 500mg 2 tablet orally twice a day after food will be given for one month

with follow ups of 15th and 30th day. comparison group will be taking Tab. Atorvastatin 10 mg once a day after food at night orally.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Newly detected case of Hyperlipidemia Patients.

排除标准

  • Plasma levels greater than equals to 240 mg/dL for Total cholesterol, greater than equals to 190 mg/dL for Low-density lipoprotein, and greater than equals to 500 mg/dL for Triglycerides.
  • Pregnant women & lactating mothers.
  • Patient with renal, hepatic, coronary heart diseases.

研究者

发起方
Vd Vaishnavi Bhausaheb Ghodake
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Vd Vaishnavi Bhausaheb Ghodake

Dr. D.Y. Patil College of Ayurveda and Research Centre

研究点 (1)

Loading locations...

相似试验

A Study to Evaluate the Benefit of a Herbal... | 临床试验